DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Schwimmer JB, Lavine JE, Wilson LA. , et al; NASH CRN.
In children with nonalcoholic fatty liver disease, cysteamine bitartrate delayed release improves liver enzymes but does not reduce disease activity scores.
Gastroenterology 2016;
151 (06) 1141-1154.e9
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.